litlas
Log inCreate account

Thomas F. Baumert

Active 1996–2025

157
Papers
20,207
Citations
84
h-index
152
i10-index

Citations

Citations per year for Thomas F. Baumert1992: 1 citations1995: 1 citations1998: 2 citations1999: 12 citations2000: 15 citations2001: 17 citations2002: 27 citations2003: 32 citations2004: 31 citations2005: 35 citations2006: 61 citations2007: 125 citations2008: 109 citations2009: 95 citations2010: 119 citations2011: 130 citations2012: 168 citations2013: 219 citations2014: 239 citations2015: 126 citations2016: 149 citations2017: 125 citations2018: 174 citations2019: 561 citations2020: 832 citations2021: 965 citations2022: 725 citations2023: 528 citations2024: 999 citations2025: 401 citations2026: 11 citations1993–1994: no citations, so these years are not shown1996–1997: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,749 citing papers, 21.4% of this breakdownChina: 1,544 citing papers, 18.9% of this breakdownGermany: 611 citing papers, 7.5% of this breakdownFrance: 484 citing papers, 5.9% of this breakdownUnited Kingdom: 460 citing papers, 5.6% of this breakdownItaly: 295 citing papers, 3.6% of this breakdownJapan: 259 citing papers, 3.2% of this breakdownCanada: 203 citing papers, 2.5% of this breakdownSpain: 198 citing papers, 2.4% of this breakdownAustralia: 161 citing papers, 2% of this breakdownSwitzerland: 142 citing papers, 1.8% of this breakdownIndia: 139 citing papers, 1.7% of this breakdown
0%21.4%Other 23.5%

Institutions

Fields

  • Medicine57.3%
  • Biochemistry, Genetics and Molecular Biology27.4%
  • Immunology and Microbiology6.5%
  • Neuroscience3.9%
  • Agricultural and Biological Sciences1.7%
  • Engineering0.7%
  • Other2.5%

Topics

  • Hepatitis C virus research8.4%
  • Liver Disease Diagnosis and Treatment7.4%
  • Hepatitis B Virus Studies6.3%
  • Liver physiology and pathology3.4%
  • Extracellular vesicles in disease1.9%
  • MicroRNA in disease regulation1.9%
  • Other70.7%

Coauthors

All papers

Open in search
  1. Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives

    Authors: Natascha Roehlen, Émilie Crouchet, Thomas F. Baumert - Cells 2020 cited by 1,194

  2. A human liver cell atlas reveals heterogeneity and epithelial progenitors

    Authors: Nadim Aizarani, Antonio Saviano, Sagar, Laurent Mailly, Sarah Durand, Josip S. Herman, Patrick Pessaux, Thomas F. Baumert, Dominic Grün - Nature, Nat. 2019 cited by 1,200

  3. Tight junction proteins in gastrointestinal and liver disease

    Authors: Mirjam B. Zeisel, Punita Dhawan, Thomas F. Baumert - Gut 2018 cited by 351

  4. Protein kinase D at the Golgi controls NLRP3 inflammasome activation

    Authors: Zhirong Zhang, G Mészáros, Wanting He, Yanfang Xu, Helena de Fatima Magliarelli, Laurent Mailly, Michael Mihlan, Yansheng Liu, Marta Puig Gámez, Alexander Goginashvili, Adrien Pasquier, Olga Bielska, Bénédicte Neven, Pierre Quartier, Rudolf Aebersold, Thomas F. Baumert, Philippe Georgel, Jiahuai Han, Roméo Ricci - The Journal of Experimental Medicine 2017 cited by 283

  5. Single-cell genomics and spatial transcriptomics: Discovery of novel cell states and cellular interactions in liver physiology and disease biology

    Authors: Antonio Saviano, Neil C. Henderson, Thomas F. Baumert - Journal of Hepatology 2020 cited by 277

  6. The scientific basis of combination therapy for chronic hepatitis B functional cure

    Authors: Seng Gee Lim, Thomas F. Baumert, Carolina Boni, Ed Gane, Massimo Levrero, Anna S. Lok, Mala K. Maini, Norah A. Terrault, Fabien Zoulim - Nature Reviews Gastroenterology & Hepatology 2023 cited by 156

  7. miR-122 – A key factor and therapeutic target in liver disease

    Authors: Simonetta Bandiera, Sébastien Pfeffer, Thomas F. Baumert, Mirjam B. Zeisel - Journal of Hepatology 2014 cited by 627

  8. The circadian clock and liver function in health and disease

    Authors: Atish Mukherji, Shannon M. Bailey, Bart Staels, Thomas F. Baumert - Journal of Hepatology 2019 cited by 231

  9. Molecular signatures of long-term hepatocellular carcinoma risk in nonalcoholic fatty liver disease

    Authors: Naoto Fujiwara, Naoto Kubota, Émilie Crouchet, Bhuvaneswari Koneru, Cesia A. Marquez, Arun Kumar Jajoriya, Gayatri Panda, Tongqi Qian, Shijia Zhu, Nicolas Goossens, Xiaochen Wang, Shuang Liang, Zhenyu Zhong, Sara Lewis, Bachir Taouli, Myron Schwartz, Maria Isabel Fiel, Amit G. Singal, Jorge A. Marrero, Austin J. Fobar, Neehar D. Parikh, Indu Raman, Quan‐Zhen Li, Masataka Taguri, Atsushi Ono, Hiroshi Aikata, Takashi Nakahara, Hayato Nakagawa, Yuki Matsushita, Ryosuke Tateishi, Kazuhiko Koike, Masahiro Kobayashi, Takaaki Higashi, Shigeki Nakagawa, Yo‐ichi Yamashita, Toru Beppu, Hideo Baba, Hiromitsu Kumada, Kazuaki Chayama, Thomas F. Baumert, Yujin Hoshida - Science Translational Medicine 2022 cited by 115

  10. Exosome-mediated transmission of hepatitis C virus between human hepatoma Huh7.5 cells

    Authors: Vedashree Ramakrishnaiah, Christine Thumann, Isabel Fofana, François Habersetzer, Qiuwei Pan, Petra E. de Ruiter, Rob Willemsen, Jeroen Demmers, V. Stalin Raj, Guido Jenster, Jaap Kwekkeboom, Hugo W. Tilanus, Bart L. Haagmans, Thomas F. Baumert, Luc J. W. van der Laan - National Academy of Sciences, Proceedings of the National Academy of Sciences 2013 cited by 495

  11. Tight Junction Protein Signaling and Cancer Biology

    Authors: Zeina Nehme, Natascha Roehlen, Punita Dhawan, Thomas F. Baumert - Cells 2023 cited by 83

  12. HCV-Induced Epigenetic Changes Associated With Liver Cancer Risk Persist After Sustained Virologic Response

    Authors: Nourdine Hamdane, Frank Jühling, Émilie Crouchet, Houssein El Saghire, Christine Thumann, Marine A. Oudot, Simonetta Bandiera, Antonio Saviano, Clara Ponsolles, Armando Andres Roca Suarez, Li Shen, Naoto Fujiwara, Atsushi Ono, Irwin Davidson, Nabeel Bardeesy, Christian Schmidl, Christoph Bock, Catherine Schuster, Joachim Lupberger, François Habersetzer, Michel Doffoël, Tullio Piardi, Danièle Sommacale, Michio Imamura, Takuro Uchida, Hideki Ohdan, Hiroshi Aikata, Kazuaki Chayama, Tujana Boldanova, Patrick Pessaux, Bryan C. Fuchs, Yujin Hoshida, Mirjam B. Zeisel, François H.T. Duong, Thomas F. Baumert - Gastroenterology 2019 cited by 269

  13. EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy

    Authors: Joachim Lupberger, Mirjam B. Zeisel, Fei Xiao, Christine Thumann, Isabel Fofana, Laetitia Zona, Christopher Davis, Christopher Mee, Marine Turek, Sebastian Gorke, Cathy Royer, Benoit Fischer, Muhammad Zahid, Dimitri Lavillette, Judith Fresquet, François‐Loïc Cosset, S. Michael Rothenberg, Thomas Pietschmann, Arvind H. Patel, Patrick Pessaux, Michel Doffoël, Wolfgang Raffelsberger, Olivier Poch, Jane A. McKeating, Laurent Brino, Thomas F. Baumert - Nature Medicine 2011 cited by 692

  14. A monoclonal antibody targeting nonjunctional claudin-1 inhibits fibrosis in patient-derived models by modulating cell plasticity

    Authors: Natascha Roehlen, Antonio Saviano, Houssein El Saghire, Émilie Crouchet, Zeina Nehme, Fabio Del Zompo, Frank Jühling, Marine A. Oudot, Sarah Durand, François H.T. Duong, Sara Cherradi, Víctor González-Motos, Nuno Almeida, Clara Ponsolles, Laura Heydmann, Tessa Ostyn, Antonin Lallement, Patrick Pessaux, Emanuele Felli, Andrea Cavalli, Jacopo Sgrignani, Christine Thumann, Olga S. Koutsopoulos, Bryan C. Fuchs, Yujin Hoshida, Maike Hofmann, Mogens Vyberg, Birgitte Martine Viuff, Elisabeth D. Galsgaard, Greg Elson, Alberto Toso, Markus Meyer, Roberto Iacone, Tamás Schweighoffer, Geoffrey Teixeira, Solange Moll, Claudio De Vito, Tania Roskams, Irwin Davidson, Danijela Heide, Mathias Heikenwälder, Mirjam B. Zeisel, Joachim Lupberger, Laurent Mailly, Catherine Schuster, Thomas F. Baumert - Science Translational Medicine 2022 cited by 48

  15. Interferon-inducible MX2 is a host restriction factor of hepatitis B virus replication

    Authors: Yongxiang Wang, Matthias Niklasch, Tiantian Liu, Yang Wang, Bisheng Shi, Wenjie Yuan, Thomas F. Baumert, Zhenghong Yuan, Shuping Tong, Michael Nassal, Yu‐Mei Wen, Michael Nassal, Yu‐Mei Wen - Journal of Hepatology 2019 cited by 117

  16. Treatment of HCC with claudin-1-specific antibodies suppresses carcinogenic signaling and reprograms the tumor microenvironment

    Authors: Natascha Roehlen, Marion Müller, Zeina Nehme, Émilie Crouchet, Frank Jühling, Fabio Del Zompo, Sara Cherradi, François H.T. Duong, Nuno Almeida, Antonio Saviano, Mirian Fernández-Vaquero, Tobias Riedl, Houssein El Saghire, Sarah Durand, Clara Ponsolles, Marine A. Oudot, Romain Martin, Nicolas Brignon, Emanuele Felli, Patrick Pessaux, Antonin Lallement, Irwin Davidson, Simonetta Bandiera, Christine Thumann, Patrice Marchand, Solange Moll, Brandon Nicolay, Nabeel Bardeesy, Yujin Hoshida, Mathias Heikenwälder, Roberto Iacone, Alberto Toso, Markus Meyer, Greg Elson, Tamás Schweighoffer, Geoffrey Teixeira, Mirjam B. Zeisel, Patrice Laquerrière, Joachim Lupberger, Catherine Schuster, Laurent Mailly, Thomas F. Baumert - Journal of Hepatology 2022 cited by 45

  17. Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C

    Authors: Jan M. Pestka, Mirjam B. Zeisel, Edith Bläser, Peter Schürmann, Birke Bartosch, François‐Loïc Cosset, Arvind H. Patel, Helga Meisel, Jens Baumert, Sergei Viazov, Kay Rispeter, Hubert E. Blum, Michael Roggendorf, Thomas F. Baumert - National Academy of Sciences, Proceedings of the National Academy of Sciences 2007 cited by 555

  18. Cystic fibrosis-related liver disease: Clinical presentations, diagnostic and monitoring approaches in the era of CFTR modulator therapies

    Authors: Jérémy Dana, Dominique Debray, Aurélie Bèaufrere, Sophie Hillaire, Monique Fabrè, Caroline Reinhold, Thomas F. Baumert, Laureline Berteloot, Valérie Vilgrain - Journal of Hepatology 2021 cited by 101

  19. Targeting clinical epigenetic reprogramming for chemoprevention of metabolic and viral hepatocellular carcinoma

    Authors: Frank Jühling, Nourdine Hamdane, Émilie Crouchet, Li Shen, Houssein El Saghire, Atish Mukherji, Naoto Fujiwara, Marine A. Oudot, Christine Thumann, Antonio Saviano, Armando Andres Roca Suarez, Kaku Goto, Ricard Masia, Mozhdeh Sojoodi, Gunisha Arora, Hiroshi Aikata, Atsushi Ono, Parissa Tabrizian, Myron Schwartz, Stephen J. Polyak, Irwin Davidson, Christian Schmidl, Christoph Bock, Catherine Schuster, Kazuaki Chayama, Patrick Pessaux, Kenneth K. Tanabe, Yujin Hoshida, Mirjam B. Zeisel, François H.T. Duong, Bryan C. Fuchs, Thomas F. Baumert - Gut 2020 cited by 95

  20. Molecular Signature Predictive of Long-Term Liver Fibrosis Progression to Inform Antifibrotic Drug Development

    Authors: Tongqi Qian, Naoto Fujiwara, Bhuvaneswari Koneru, Atsushi Ono, Naoto Kubota, Arun Kumar Jajoriya, Matthew Tung, Émilie Crouchet, Won‐Min Song, Cesia A. Marquez, Gayatri Panda, Ayaka Hoshida, Indu Raman, Quan‐Zhen Li, Cheryl Lewis, Adam C. Yopp, Nicole E. Rich, Amit G. Singal, Shigeki Nakagawa, Nicolas Goossens, Takaaki Higashi, Anna P. Koh, C. Billie Bian, Hiroki Hoshida, Parissa Tabrizian, Ganesh Gunasekaran, Sander Florman, Myron Schwarz, Spiros Hiotis, Takashi Nakahara, Hiroshi Aikata, Eisuke Murakami, Toru Beppu, Hideo Baba, rew Warren, Sangeeta N. Bhatia, Masahiro Kobayashi, Hiromitsu Kumada, Austin J. Fobar, Neehar D. Parikh, Jorge A. Marrero, Steve Rwema, Venugopalan D. Nair, Manishkumar Patel, Seunghee Kim‐Schulze, Kathleen E. Corey, Jacqueline G. O’Leary, Göran B. Klintmalm, David L. Thomas, Mohammed Dibas, Gerardo Rodriguez, Bin Zhang, Scott L. Friedman, Thomas F. Baumert, Bryan C. Fuchs, Kazuaki Chayama, Shijia Zhu, Raymond T. Chung, Yujin Hoshida - Gastroenterology 2021 cited by 39

  21. A targeted functional RNA interference screen uncovers glypican 5 as an entry factor for hepatitis B and D viruses

    Authors: Éloi R. Verrier, Che C. Colpitts, C Bach, Laura Heydmann, Amélie Weiss, Mickaël Renaud, Sarah Durand, François Habersetzer, David Durantel, Georges Abou-Jaoudé, Maria M. López Ledesma, Daniel J. Felmlee, Magali Soumillon, Tom Croonenborghs, Nathalie Pochet, Michael Nassal, Catherine Schuster, Laurent Brino, Camille Sureau, Mirjam B. Zeisel, Thomas F. Baumert - Hepatology 2015 cited by 169

  22. Phenotype and function of HBV-specific T cells is determined by the targeted epitope in addition to the stage of infection

    Authors: Ruben C. Hoogeveen, Maxwell Robidoux, Tatjana Schwarz, Laura Heydmann, James A. Cheney, Daniel Kvistad, Jasneet Aneja, Juliana Gil Melgaço, Carlos Augusto Fernandes, Raymond T. Chung, André Boonstra, Arthur Y Kim, Thomas F. Baumert, Jörg Timm, Lia Laura Lewis‐Ximenez, Pierre Tonnerre, Georg M. Lauer - Gut 2018 cited by 136

  23. Radiomics in hepatocellular carcinoma: a quantitative review

    Authors: Taiga Wakabayashi, Farid Ouhmich, Cristians Gonzalez-Cabrera, Emanuele Felli, Antonio Saviano, Vincent Agnus, Peter Savadjiev, Thomas F. Baumert, Patrick Pessaux, Jacques Marescaux, B. Gallix - Hepatology International 2019 cited by 131

  24. Viral manipulation of STAT3: Evade, exploit, and injure

    Authors: Armando Andres Roca Suarez, Nicolaas Van Renne, Thomas F. Baumert, Joachim Lupberger - PLoS Pathogens 2018 cited by 105